nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC28A3—islet of Langerhans—type 2 diabetes mellitus	0.0121	0.0846	CbGeAlD
Fludarabine—SLC28A3—pancreas—type 2 diabetes mellitus	0.00849	0.0595	CbGeAlD
Fludarabine—SLC28A3—adipose tissue—type 2 diabetes mellitus	0.0077	0.054	CbGeAlD
Fludarabine—POLA1—retina—type 2 diabetes mellitus	0.00726	0.0508	CbGeAlD
Fludarabine—RRM1—islet of Langerhans—type 2 diabetes mellitus	0.00674	0.0472	CbGeAlD
Fludarabine—RRM1—retina—type 2 diabetes mellitus	0.00576	0.0403	CbGeAlD
Fludarabine—SLC29A1—islet of Langerhans—type 2 diabetes mellitus	0.00548	0.0384	CbGeAlD
Fludarabine—RRM1—nephron tubule—type 2 diabetes mellitus	0.00542	0.038	CbGeAlD
Fludarabine—POLA1—adipose tissue—type 2 diabetes mellitus	0.00541	0.0379	CbGeAlD
Fludarabine—DCK—islet of Langerhans—type 2 diabetes mellitus	0.00523	0.0367	CbGeAlD
Fludarabine—RRM1—cardiovascular system—type 2 diabetes mellitus	0.00487	0.0341	CbGeAlD
Fludarabine—RRM1—kidney—type 2 diabetes mellitus	0.00477	0.0334	CbGeAlD
Fludarabine—RRM1—pancreas—type 2 diabetes mellitus	0.00474	0.0332	CbGeAlD
Fludarabine—RRM1—cortex of kidney—type 2 diabetes mellitus	0.00464	0.0325	CbGeAlD
Fludarabine—DCK—retina—type 2 diabetes mellitus	0.00447	0.0313	CbGeAlD
Fludarabine—RRM1—adipose tissue—type 2 diabetes mellitus	0.0043	0.0301	CbGeAlD
Fludarabine—DCK—nephron tubule—type 2 diabetes mellitus	0.00421	0.0295	CbGeAlD
Fludarabine—S-Adenosylmethionine—MAT1A—type 2 diabetes mellitus	0.00411	0.176	CrCbGaD
Fludarabine—SLC29A1—cardiovascular system—type 2 diabetes mellitus	0.00396	0.0277	CbGeAlD
Fludarabine—SLC29A1—kidney—type 2 diabetes mellitus	0.00388	0.0271	CbGeAlD
Fludarabine—SLC29A1—pancreas—type 2 diabetes mellitus	0.00385	0.027	CbGeAlD
Fludarabine—POLA1—liver—type 2 diabetes mellitus	0.0038	0.0266	CbGeAlD
Fludarabine—Ribavirin—ENPP1—type 2 diabetes mellitus	0.00379	0.162	CrCbGaD
Fludarabine—SLC29A1—cortex of kidney—type 2 diabetes mellitus	0.00377	0.0264	CbGeAlD
Fludarabine—DCK—pancreas—type 2 diabetes mellitus	0.00368	0.0258	CbGeAlD
Fludarabine—DCK—cortex of kidney—type 2 diabetes mellitus	0.00361	0.0253	CbGeAlD
Fludarabine—SLC29A1—adipose tissue—type 2 diabetes mellitus	0.00349	0.0245	CbGeAlD
Fludarabine—DCK—adipose tissue—type 2 diabetes mellitus	0.00334	0.0234	CbGeAlD
Fludarabine—RRM1—liver—type 2 diabetes mellitus	0.00301	0.0211	CbGeAlD
Fludarabine—S-Adenosylmethionine—CBS—type 2 diabetes mellitus	0.00265	0.113	CrCbGaD
Fludarabine—SLC29A1—liver—type 2 diabetes mellitus	0.00245	0.0172	CbGeAlD
Fludarabine—DCK—liver—type 2 diabetes mellitus	0.00234	0.0164	CbGeAlD
Fludarabine—Azacitidine—DNMT1—type 2 diabetes mellitus	0.00198	0.0847	CrCbGaD
Fludarabine—Adenosine monophosphate—PRKAA1—type 2 diabetes mellitus	0.00168	0.072	CrCbGaD
Fludarabine—Vidarabine—DPP4—type 2 diabetes mellitus	0.00167	0.0716	CrCbGaD
Fludarabine—Flavin adenine dinucleotide—NOS1—type 2 diabetes mellitus	0.00157	0.0672	CrCbGaD
Fludarabine—Adenosine triphosphate—PRKAA1—type 2 diabetes mellitus	0.00146	0.0624	CrCbGaD
Fludarabine—Adenosine—DPP4—type 2 diabetes mellitus	0.00134	0.0572	CrCbGaD
Fludarabine—Adenosine triphosphate—ABCC8—type 2 diabetes mellitus	0.00086	0.0368	CrCbGaD
Fludarabine—Adenosine triphosphate—AKT1—type 2 diabetes mellitus	0.00069	0.0295	CrCbGaD
Fludarabine—Adenosine monophosphate—SRC—type 2 diabetes mellitus	0.00068	0.0291	CrCbGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—type 2 diabetes mellitus	0.000521	0.00251	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.00052	0.00251	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.00052	0.00251	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000508	0.000811	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000508	0.00245	CbGpPWpGaD
Fludarabine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000507	0.000809	CcSEcCtD
Fludarabine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000507	0.000809	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000506	0.00244	CbGpPWpGaD
Fludarabine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000505	0.000806	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000505	0.00244	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000505	0.00243	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000503	0.000802	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000502	0.00242	CbGpPWpGaD
Fludarabine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000501	0.0008	CcSEcCtD
Fludarabine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000501	0.000799	CcSEcCtD
Fludarabine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000498	0.000795	CcSEcCtD
Fludarabine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000495	0.000791	CcSEcCtD
Fludarabine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000495	0.000789	CcSEcCtD
Fludarabine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000494	0.000788	CcSEcCtD
Fludarabine—Malaise—Metformin—type 2 diabetes mellitus	0.000489	0.00078	CcSEcCtD
Fludarabine—Alopecia—Losartan—type 2 diabetes mellitus	0.000489	0.00078	CcSEcCtD
Fludarabine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000488	0.000779	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000488	0.00236	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.000488	0.00235	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000487	0.00235	CbGpPWpGaD
Fludarabine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000487	0.000777	CcSEcCtD
Fludarabine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000486	0.000776	CcSEcCtD
Fludarabine—Oedema—Valsartan—type 2 diabetes mellitus	0.000486	0.000775	CcSEcCtD
Fludarabine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000486	0.000775	CcSEcCtD
Fludarabine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000485	0.000774	CcSEcCtD
Fludarabine—Infection—Valsartan—type 2 diabetes mellitus	0.000482	0.00077	CcSEcCtD
Fludarabine—Rash—Glipizide—type 2 diabetes mellitus	0.000482	0.00077	CcSEcCtD
Fludarabine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000482	0.000769	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000482	0.000769	CcSEcCtD
Fludarabine—RRM1—Metabolism—AANAT—type 2 diabetes mellitus	0.000481	0.00232	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGDS—type 2 diabetes mellitus	0.000481	0.00232	CbGpPWpGaD
Fludarabine—Oedema—Orlistat—type 2 diabetes mellitus	0.00048	0.000766	CcSEcCtD
Fludarabine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00048	0.000766	CcSEcCtD
Fludarabine—Headache—Glipizide—type 2 diabetes mellitus	0.000479	0.000765	CcSEcCtD
Fludarabine—Infection—Orlistat—type 2 diabetes mellitus	0.000477	0.000761	CcSEcCtD
Fludarabine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000476	0.00076	CcSEcCtD
Fludarabine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000475	0.000759	CcSEcCtD
Fludarabine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000475	0.000758	CcSEcCtD
Fludarabine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000474	0.000757	CcSEcCtD
Fludarabine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000473	0.000754	CcSEcCtD
Fludarabine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000471	0.000752	CcSEcCtD
Fludarabine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000471	0.000751	CcSEcCtD
Fludarabine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00047	0.00075	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000468	0.00226	CbGpPWpGaD
Fludarabine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000465	0.000743	CcSEcCtD
Fludarabine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000464	0.00074	CcSEcCtD
Fludarabine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000463	0.000739	CcSEcCtD
Fludarabine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000462	0.000737	CcSEcCtD
Fludarabine—Myalgia—Metformin—type 2 diabetes mellitus	0.000461	0.000736	CcSEcCtD
Fludarabine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000461	0.000736	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000459	0.00222	CbGpPWpGaD
Fludarabine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000459	0.000733	CcSEcCtD
Fludarabine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000458	0.000731	CcSEcCtD
Fludarabine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000457	0.000729	CcSEcCtD
Fludarabine—RRM1—Metabolism—GPD2—type 2 diabetes mellitus	0.000456	0.0022	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CDO1—type 2 diabetes mellitus	0.000456	0.0022	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000456	0.000728	CcSEcCtD
Fludarabine—Discomfort—Metformin—type 2 diabetes mellitus	0.000456	0.000727	CcSEcCtD
Fludarabine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000456	0.000727	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—PPP2CA—type 2 diabetes mellitus	0.000455	0.00219	CbGpPWpGaD
Fludarabine—Nausea—Glipizide—type 2 diabetes mellitus	0.000454	0.000725	CcSEcCtD
Fludarabine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000454	0.000724	CcSEcCtD
Fludarabine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000452	0.000722	CcSEcCtD
Fludarabine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000452	0.000721	CcSEcCtD
Fludarabine—Pain—Gliclazide—type 2 diabetes mellitus	0.000452	0.000721	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000452	0.00218	CbGpPWpGaD
Fludarabine—Rash—Glimepiride—type 2 diabetes mellitus	0.00045	0.000718	CcSEcCtD
Fludarabine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00045	0.000718	CcSEcCtD
Fludarabine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000449	0.000716	CcSEcCtD
Fludarabine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000448	0.000715	CcSEcCtD
Fludarabine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000448	0.000715	CcSEcCtD
Fludarabine—Headache—Glimepiride—type 2 diabetes mellitus	0.000447	0.000714	CcSEcCtD
Fludarabine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000447	0.000713	CcSEcCtD
Fludarabine—Cough—Irbesartan—type 2 diabetes mellitus	0.000446	0.000712	CcSEcCtD
Fludarabine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000446	0.000711	CcSEcCtD
Fludarabine—Anaemia—Losartan—type 2 diabetes mellitus	0.000445	0.00071	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000442	0.000706	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000442	0.00213	CbGpPWpGaD
Fludarabine—Agitation—Losartan—type 2 diabetes mellitus	0.000442	0.000706	CcSEcCtD
Fludarabine—Oedema—Metformin—type 2 diabetes mellitus	0.000442	0.000706	CcSEcCtD
Fludarabine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000441	0.000703	CcSEcCtD
Fludarabine—Infection—Metformin—type 2 diabetes mellitus	0.000439	0.000701	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000437	0.000698	CcSEcCtD
Fludarabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000436	0.000696	CcSEcCtD
Fludarabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000436	0.000695	CcSEcCtD
Fludarabine—RRM1—Metabolism—AK1—type 2 diabetes mellitus	0.000435	0.0021	CbGpPWpGaD
Fludarabine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000435	0.000695	CcSEcCtD
Fludarabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000435	0.000695	CcSEcCtD
Fludarabine—Malaise—Losartan—type 2 diabetes mellitus	0.000434	0.000693	CcSEcCtD
Fludarabine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000434	0.000692	CcSEcCtD
Fludarabine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000434	0.000692	CcSEcCtD
Fludarabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000433	0.000691	CcSEcCtD
Fludarabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000433	0.000691	CcSEcCtD
Fludarabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000431	0.000688	CcSEcCtD
Fludarabine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000431	0.000688	CcSEcCtD
Fludarabine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00043	0.000687	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	0.000428	0.00206	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000428	0.000682	CcSEcCtD
Fludarabine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000427	0.000682	CcSEcCtD
Fludarabine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000424	0.000677	CcSEcCtD
Fludarabine—DCK—Metabolism—BHMT—type 2 diabetes mellitus	0.000424	0.00204	CbGpPWpGaD
Fludarabine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000423	0.000676	CcSEcCtD
Fludarabine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000423	0.000675	CcSEcCtD
Fludarabine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000422	0.000674	CcSEcCtD
Fludarabine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000422	0.000674	CcSEcCtD
Fludarabine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000422	0.000674	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000422	0.00204	CbGpPWpGaD
Fludarabine—Anorexia—Metformin—type 2 diabetes mellitus	0.000422	0.000673	CcSEcCtD
Fludarabine—Cough—Losartan—type 2 diabetes mellitus	0.00042	0.00067	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000419	0.000669	CcSEcCtD
Fludarabine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000419	0.000669	CcSEcCtD
Fludarabine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000419	0.000668	CcSEcCtD
Fludarabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000418	0.000667	CcSEcCtD
Fludarabine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000417	0.000666	CcSEcCtD
Fludarabine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000417	0.000666	CcSEcCtD
Fludarabine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000417	0.000666	CcSEcCtD
Fludarabine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000416	0.000665	CcSEcCtD
Fludarabine—Constipation—Valsartan—type 2 diabetes mellitus	0.000415	0.000663	CcSEcCtD
Fludarabine—Infection—Irbesartan—type 2 diabetes mellitus	0.000415	0.000662	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000414	0.000661	CcSEcCtD
Fludarabine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000414	0.00066	CcSEcCtD
Fludarabine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000413	0.000659	CcSEcCtD
Fludarabine—Pain—Orlistat—type 2 diabetes mellitus	0.00041	0.000655	CcSEcCtD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.00041	0.00198	CbGpPWpGaD
Fludarabine—Arthralgia—Losartan—type 2 diabetes mellitus	0.00041	0.000654	CcSEcCtD
Fludarabine—Myalgia—Losartan—type 2 diabetes mellitus	0.00041	0.000654	CcSEcCtD
Fludarabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000409	0.000653	CcSEcCtD
Fludarabine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000409	0.000653	CcSEcCtD
Fludarabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000409	0.000652	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000406	0.00196	CbGpPWpGaD
Fludarabine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000406	0.000648	CcSEcCtD
Fludarabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000406	0.000647	CcSEcCtD
Fludarabine—Discomfort—Losartan—type 2 diabetes mellitus	0.000405	0.000646	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000405	0.00195	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000403	0.000644	CcSEcCtD
Fludarabine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000403	0.000644	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000403	0.000643	CcSEcCtD
Fludarabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000403	0.000643	CcSEcCtD
Fludarabine—RRM1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000402	0.00194	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000402	0.00194	CbGpPWpGaD
Fludarabine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000398	0.000635	CcSEcCtD
Fludarabine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000397	0.000634	CcSEcCtD
Fludarabine—Confusional state—Losartan—type 2 diabetes mellitus	0.000396	0.000632	CcSEcCtD
Fludarabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000395	0.000631	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000394	0.0019	CbGpPWpGaD
Fludarabine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000394	0.000629	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000394	0.0019	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000393	0.000627	CcSEcCtD
Fludarabine—Oedema—Losartan—type 2 diabetes mellitus	0.000393	0.000627	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.00039	0.00188	CbGpPWpGaD
Fludarabine—Infection—Losartan—type 2 diabetes mellitus	0.00039	0.000623	CcSEcCtD
Fludarabine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000389	0.000622	CcSEcCtD
Fludarabine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000389	0.000621	CcSEcCtD
Fludarabine—RRM1—Metabolism—G6PC—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HBA2—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ND1—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENPP1—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000388	0.00187	CbGpPWpGaD
Fludarabine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000385	0.000615	CcSEcCtD
Fludarabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000385	0.000614	CcSEcCtD
Fludarabine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000384	0.000614	CcSEcCtD
Fludarabine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000383	0.000611	CcSEcCtD
Fludarabine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000382	0.00061	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000382	0.000609	CcSEcCtD
Fludarabine—Fatigue—Metformin—type 2 diabetes mellitus	0.000381	0.000609	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00038	0.000607	CcSEcCtD
Fludarabine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00038	0.000606	CcSEcCtD
Fludarabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000379	0.000605	CcSEcCtD
Fludarabine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000379	0.000605	CcSEcCtD
Fludarabine—Agitation—Ramipril—type 2 diabetes mellitus	0.000379	0.000605	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000379	0.00183	CbGpPWpGaD
Fludarabine—Constipation—Metformin—type 2 diabetes mellitus	0.000378	0.000604	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000376	0.00182	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GCGR—type 2 diabetes mellitus	0.000376	0.00181	CbGpPWpGaD
Fludarabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000375	0.000598	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000374	0.00181	CbGpPWpGaD
Fludarabine—Anorexia—Losartan—type 2 diabetes mellitus	0.000374	0.000598	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000374	0.00181	CbGpPWpGaD
Fludarabine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000374	0.000597	CcSEcCtD
Fludarabine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000374	0.000597	CcSEcCtD
Fludarabine—Malaise—Ramipril—type 2 diabetes mellitus	0.000372	0.000594	CcSEcCtD
Fludarabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000372	0.000594	CcSEcCtD
Fludarabine—S-Adenosylmethionine—CYP2E1—type 2 diabetes mellitus	0.000372	0.0159	CrCbGaD
Fludarabine—Rash—Glyburide—type 2 diabetes mellitus	0.000371	0.000592	CcSEcCtD
Fludarabine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000371	0.000592	CcSEcCtD
Fludarabine—DCK—Metabolism—PTGDS—type 2 diabetes mellitus	0.000371	0.00179	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AANAT—type 2 diabetes mellitus	0.000371	0.00179	CbGpPWpGaD
Fludarabine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000369	0.00059	CcSEcCtD
Fludarabine—Headache—Glyburide—type 2 diabetes mellitus	0.000369	0.000589	CcSEcCtD
Fludarabine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000367	0.000586	CcSEcCtD
Fludarabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000364	0.000582	CcSEcCtD
Fludarabine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000363	0.000579	CcSEcCtD
Fludarabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000362	0.000577	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00036	0.000575	CcSEcCtD
Fludarabine—Cough—Ramipril—type 2 diabetes mellitus	0.00036	0.000575	CcSEcCtD
Fludarabine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00036	0.000574	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000358	0.000571	CcSEcCtD
Fludarabine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000358	0.000571	CcSEcCtD
Fludarabine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000358	0.000571	CcSEcCtD
Fludarabine—Pain—Irbesartan—type 2 diabetes mellitus	0.000357	0.00057	CcSEcCtD
Fludarabine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000357	0.00057	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYTB—type 2 diabetes mellitus	0.000355	0.00171	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000355	0.00171	CbGpPWpGaD
Fludarabine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000354	0.000564	CcSEcCtD
Fludarabine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000353	0.000563	CcSEcCtD
Fludarabine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000351	0.000561	CcSEcCtD
Fludarabine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000351	0.000561	CcSEcCtD
Fludarabine—DCK—Metabolism—CDO1—type 2 diabetes mellitus	0.000351	0.00169	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPD2—type 2 diabetes mellitus	0.000351	0.00169	CbGpPWpGaD
Fludarabine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00035	0.000559	CcSEcCtD
Fludarabine—Nausea—Glyburide—type 2 diabetes mellitus	0.00035	0.000558	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PSMD6—type 2 diabetes mellitus	0.000349	0.00168	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000349	0.00168	CbGpPWpGaD
Fludarabine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000348	0.000556	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000348	0.00168	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000347	0.00167	CbGpPWpGaD
Fludarabine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000347	0.000554	CcSEcCtD
Fludarabine—RRM1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000346	0.00167	CbGpPWpGaD
Fludarabine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000346	0.000552	CcSEcCtD
Fludarabine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000344	0.000549	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000344	0.00166	CbGpPWpGaD
Fludarabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000344	0.000549	CcSEcCtD
Fludarabine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000344	0.000548	CcSEcCtD
Fludarabine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000341	0.000545	CcSEcCtD
Fludarabine—Confusional state—Ramipril—type 2 diabetes mellitus	0.00034	0.000542	CcSEcCtD
Fludarabine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00034	0.000542	CcSEcCtD
Fludarabine—Fatigue—Losartan—type 2 diabetes mellitus	0.000339	0.00054	CcSEcCtD
Fludarabine—Oedema—Ramipril—type 2 diabetes mellitus	0.000337	0.000538	CcSEcCtD
Fludarabine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000337	0.000538	CcSEcCtD
Fludarabine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000336	0.000536	CcSEcCtD
Fludarabine—Constipation—Losartan—type 2 diabetes mellitus	0.000336	0.000536	CcSEcCtD
Fludarabine—Pain—Losartan—type 2 diabetes mellitus	0.000336	0.000536	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000335	0.00162	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AK1—type 2 diabetes mellitus	0.000335	0.00162	CbGpPWpGaD
Fludarabine—Rash—Gliclazide—type 2 diabetes mellitus	0.000333	0.000532	CcSEcCtD
Fludarabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000333	0.000531	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000333	0.0016	CbGpPWpGaD
Fludarabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000332	0.00053	CcSEcCtD
Fludarabine—Headache—Gliclazide—type 2 diabetes mellitus	0.000331	0.000528	CcSEcCtD
Fludarabine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00033	0.000527	CcSEcCtD
Fludarabine—RRM1—Metabolism—ACACA—type 2 diabetes mellitus	0.00033	0.00159	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—STAR—type 2 diabetes mellitus	0.00033	0.00159	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.00033	0.00159	CbGpPWpGaD
Fludarabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00033	0.000527	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.00033	0.00159	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00033	0.000526	CcSEcCtD
Fludarabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000328	0.000524	CcSEcCtD
Fludarabine—Adenosine triphosphate—ABCC2—type 2 diabetes mellitus	0.000327	0.014	CrCbGaD
Fludarabine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000326	0.00052	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000325	0.00157	CbGpPWpGaD
Fludarabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000324	0.000517	CcSEcCtD
Fludarabine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000321	0.000512	CcSEcCtD
Fludarabine—Asthenia—Metformin—type 2 diabetes mellitus	0.000317	0.000506	CcSEcCtD
Fludarabine—RRM1—Metabolism—CBS—type 2 diabetes mellitus	0.000316	0.00153	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCC8—type 2 diabetes mellitus	0.000316	0.00153	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000315	0.00152	CbGpPWpGaD
Fludarabine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000314	0.000501	CcSEcCtD
Fludarabine—Pruritus—Metformin—type 2 diabetes mellitus	0.000313	0.000499	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000311	0.0015	CbGpPWpGaD
Fludarabine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00031	0.000496	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000309	0.00149	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MAT1A—type 2 diabetes mellitus	0.000309	0.00149	CbGpPWpGaD
Fludarabine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000309	0.000493	CcSEcCtD
Fludarabine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000307	0.000491	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000307	0.00049	CcSEcCtD
Fludarabine—Rash—Valsartan—type 2 diabetes mellitus	0.000306	0.000489	CcSEcCtD
Fludarabine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000306	0.000488	CcSEcCtD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000306	0.00148	CbGpPWpGaD
Fludarabine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000305	0.000487	CcSEcCtD
Fludarabine—RRM1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000305	0.00147	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—COX2—type 2 diabetes mellitus	0.000305	0.00147	CbGpPWpGaD
Fludarabine—Headache—Valsartan—type 2 diabetes mellitus	0.000304	0.000486	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000303	0.00146	CbGpPWpGaD
Fludarabine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000303	0.000483	CcSEcCtD
Fludarabine—Rash—Orlistat—type 2 diabetes mellitus	0.000303	0.000483	CcSEcCtD
Fludarabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000302	0.000483	CcSEcCtD
Fludarabine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000302	0.000482	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000302	0.00146	CbGpPWpGaD
Fludarabine—Headache—Orlistat—type 2 diabetes mellitus	0.000301	0.00048	CcSEcCtD
Fludarabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.0003	0.000479	CcSEcCtD
Fludarabine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000299	0.000478	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000299	0.00144	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ND1—type 2 diabetes mellitus	0.000299	0.00144	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000299	0.00144	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ENPP1—type 2 diabetes mellitus	0.000299	0.00144	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HBA2—type 2 diabetes mellitus	0.000299	0.00144	CbGpPWpGaD
Fludarabine—DCK—Metabolism—G6PC—type 2 diabetes mellitus	0.000299	0.00144	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—type 2 diabetes mellitus	0.000298	0.00144	CbGpPWpGaD
Fludarabine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000296	0.000473	CcSEcCtD
Fludarabine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000295	0.000471	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000295	0.00142	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UCP2—type 2 diabetes mellitus	0.000294	0.00142	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UCP3—type 2 diabetes mellitus	0.000294	0.00142	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000294	0.00142	CbGpPWpGaD
Fludarabine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000293	0.000467	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000291	0.000464	CcSEcCtD
Fludarabine—Fatigue—Ramipril—type 2 diabetes mellitus	0.00029	0.000463	CcSEcCtD
Fludarabine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000289	0.000462	CcSEcCtD
Fludarabine—DCK—Metabolism—GCGR—type 2 diabetes mellitus	0.000289	0.0014	CbGpPWpGaD
Fludarabine—Nausea—Valsartan—type 2 diabetes mellitus	0.000288	0.00046	CcSEcCtD
Fludarabine—Constipation—Ramipril—type 2 diabetes mellitus	0.000288	0.00046	CcSEcCtD
Fludarabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000286	0.000456	CcSEcCtD
Fludarabine—Nausea—Orlistat—type 2 diabetes mellitus	0.000285	0.000455	CcSEcCtD
Fludarabine—Asthenia—Losartan—type 2 diabetes mellitus	0.000282	0.00045	CcSEcCtD
Fludarabine—Vomiting—Metformin—type 2 diabetes mellitus	0.000281	0.000449	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.00028	0.00135	CbGpPWpGaD
Fludarabine—Rash—Metformin—type 2 diabetes mellitus	0.000279	0.000445	CcSEcCtD
Fludarabine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000279	0.000445	CcSEcCtD
Fludarabine—Pruritus—Losartan—type 2 diabetes mellitus	0.000278	0.000443	CcSEcCtD
Fludarabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000278	0.000443	CcSEcCtD
Fludarabine—Headache—Metformin—type 2 diabetes mellitus	0.000277	0.000442	CcSEcCtD
Fludarabine—RRM1—Metabolism—PCK1—type 2 diabetes mellitus	0.000277	0.00133	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYTB—type 2 diabetes mellitus	0.000273	0.00132	CbGpPWpGaD
Fludarabine—DCK—Metabolism—OXCT1—type 2 diabetes mellitus	0.000273	0.00132	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000271	0.00131	CbGpPWpGaD
Fludarabine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000269	0.000429	CcSEcCtD
Fludarabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000266	0.000425	CcSEcCtD
Fludarabine—DCK—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000266	0.00128	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000265	0.00128	CbGpPWpGaD
Fludarabine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000265	0.000424	CcSEcCtD
Fludarabine—Rash—Irbesartan—type 2 diabetes mellitus	0.000263	0.00042	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000263	0.00127	CbGpPWpGaD
Fludarabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000263	0.00042	CcSEcCtD
Fludarabine—Nausea—Metformin—type 2 diabetes mellitus	0.000263	0.000419	CcSEcCtD
Fludarabine—Headache—Irbesartan—type 2 diabetes mellitus	0.000261	0.000417	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—PSMD6—type 2 diabetes mellitus	0.000261	0.00126	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.00026	0.00125	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HK1—type 2 diabetes mellitus	0.000259	0.00125	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000259	0.00125	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000259	0.00125	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000257	0.00124	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000254	0.00123	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACACA—type 2 diabetes mellitus	0.000254	0.00122	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000254	0.00122	CbGpPWpGaD
Fludarabine—DCK—Metabolism—STAR—type 2 diabetes mellitus	0.000254	0.00122	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000253	0.00122	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD3B2—type 2 diabetes mellitus	0.00025	0.00121	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LPA—type 2 diabetes mellitus	0.00025	0.00121	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—KCNJ11—type 2 diabetes mellitus	0.00025	0.00121	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GCKR—type 2 diabetes mellitus	0.00025	0.00121	CbGpPWpGaD
Fludarabine—Vomiting—Losartan—type 2 diabetes mellitus	0.00025	0.000399	CcSEcCtD
Fludarabine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000248	0.000396	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000248	0.0012	CbGpPWpGaD
Fludarabine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000248	0.000396	CcSEcCtD
Fludarabine—Rash—Losartan—type 2 diabetes mellitus	0.000248	0.000395	CcSEcCtD
Fludarabine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000247	0.000395	CcSEcCtD
Fludarabine—Headache—Losartan—type 2 diabetes mellitus	0.000246	0.000393	CcSEcCtD
Fludarabine—DCK—Metabolism—ABCC8—type 2 diabetes mellitus	0.000243	0.00117	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CBS—type 2 diabetes mellitus	0.000243	0.00117	CbGpPWpGaD
Fludarabine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000242	0.000386	CcSEcCtD
Fludarabine—RRM1—Metabolism—ALDOB—type 2 diabetes mellitus	0.00024	0.00116	CbGpPWpGaD
Fludarabine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000238	0.00038	CcSEcCtD
Fludarabine—DCK—Metabolism—COX2—type 2 diabetes mellitus	0.000234	0.00113	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000234	0.00113	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PSMD6—type 2 diabetes mellitus	0.000234	0.00113	CbGpPWpGaD
Fludarabine—Nausea—Losartan—type 2 diabetes mellitus	0.000233	0.000372	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000232	0.00112	CbGpPWpGaD
Fludarabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00023	0.000368	CcSEcCtD
Fludarabine—DCK—Metabolism—NCOA6—type 2 diabetes mellitus	0.00023	0.00111	CbGpPWpGaD
Fludarabine—DCK—Metabolism—UCP3—type 2 diabetes mellitus	0.000226	0.00109	CbGpPWpGaD
Fludarabine—DCK—Metabolism—UCP2—type 2 diabetes mellitus	0.000226	0.00109	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000226	0.00109	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PPP2CA—type 2 diabetes mellitus	0.000223	0.00108	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GLP1R—type 2 diabetes mellitus	0.000223	0.00108	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000222	0.00107	CbGpPWpGaD
Fludarabine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000214	0.000342	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND2—type 2 diabetes mellitus	0.000213	0.00103	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PCK1—type 2 diabetes mellitus	0.000213	0.00103	CbGpPWpGaD
Fludarabine—Rash—Ramipril—type 2 diabetes mellitus	0.000212	0.000339	CcSEcCtD
Fludarabine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000212	0.000339	CcSEcCtD
Fludarabine—Headache—Ramipril—type 2 diabetes mellitus	0.000211	0.000337	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000211	0.00102	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000209	0.00101	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000208	0.00101	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000208	0.001	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTR—type 2 diabetes mellitus	0.000204	0.000983	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CPT1A—type 2 diabetes mellitus	0.000204	0.000983	CbGpPWpGaD
Fludarabine—Nausea—Ramipril—type 2 diabetes mellitus	0.0002	0.000319	CcSEcCtD
Fludarabine—RRM1—Metabolism—NAMPT—type 2 diabetes mellitus	0.0002	0.000964	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HK1—type 2 diabetes mellitus	0.000199	0.000961	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HBA1—type 2 diabetes mellitus	0.000199	0.000958	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LIPC—type 2 diabetes mellitus	0.000199	0.000958	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GCK—type 2 diabetes mellitus	0.000199	0.000958	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000197	0.000952	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000196	0.000946	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000196	0.000944	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000194	0.000935	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GCKR—type 2 diabetes mellitus	0.000192	0.000928	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LPA—type 2 diabetes mellitus	0.000192	0.000928	CbGpPWpGaD
Fludarabine—DCK—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000192	0.000928	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000192	0.000928	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CETP—type 2 diabetes mellitus	0.000192	0.000924	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	0.000191	0.000921	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND2—type 2 diabetes mellitus	0.00019	0.000919	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000188	0.000908	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PRKCB—type 2 diabetes mellitus	0.000188	0.000906	CbGpPWpGaD
Fludarabine—Cytarabine—CYP3A4—type 2 diabetes mellitus	0.000185	0.00792	CrCbGaD
Fludarabine—DCK—Metabolism—ALDOB—type 2 diabetes mellitus	0.000185	0.00089	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000183	0.000883	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SREBF1—type 2 diabetes mellitus	0.000178	0.000859	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PSMD6—type 2 diabetes mellitus	0.000178	0.000859	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SNAP25—type 2 diabetes mellitus	0.000178	0.000859	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CTGF—type 2 diabetes mellitus	0.000175	0.000844	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMGCR—type 2 diabetes mellitus	0.000173	0.000836	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GLP1R—type 2 diabetes mellitus	0.000172	0.000827	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2B—type 2 diabetes mellitus	0.000171	0.000823	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000171	0.000823	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ADRA2A—type 2 diabetes mellitus	0.00017	0.000818	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	0.000167	0.000804	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000166	0.000801	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000163	0.000786	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000161	0.000777	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000161	0.000777	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC2A2—type 2 diabetes mellitus	0.00016	0.000772	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000157	0.000758	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTR—type 2 diabetes mellitus	0.000157	0.000757	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CPT1A—type 2 diabetes mellitus	0.000157	0.000757	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000155	0.00075	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000155	0.000745	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GCG—type 2 diabetes mellitus	0.000155	0.000745	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NAMPT—type 2 diabetes mellitus	0.000154	0.000742	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HBA1—type 2 diabetes mellitus	0.000153	0.000737	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LIPC—type 2 diabetes mellitus	0.000153	0.000737	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GCK—type 2 diabetes mellitus	0.000153	0.000737	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000152	0.000735	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000152	0.000733	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000149	0.000721	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000149	0.00072	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PPP2CA—type 2 diabetes mellitus	0.000149	0.000719	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CETP—type 2 diabetes mellitus	0.000147	0.000711	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000142	0.000687	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	0.000141	0.000678	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PSMD6—type 2 diabetes mellitus	0.000137	0.000661	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SNAP25—type 2 diabetes mellitus	0.000137	0.000661	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SREBF1—type 2 diabetes mellitus	0.000137	0.000661	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CTGF—type 2 diabetes mellitus	0.000135	0.000649	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMGCR—type 2 diabetes mellitus	0.000133	0.000643	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GNB3—type 2 diabetes mellitus	0.000133	0.000642	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000133	0.000642	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMOX1—type 2 diabetes mellitus	0.000133	0.000639	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CAT—type 2 diabetes mellitus	0.000131	0.000631	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000131	0.00063	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOB—type 2 diabetes mellitus	0.000127	0.000612	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PRKCB—type 2 diabetes mellitus	0.000126	0.000606	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000125	0.000605	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000124	0.000598	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000124	0.000598	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—type 2 diabetes mellitus	0.000124	0.000596	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LPL—type 2 diabetes mellitus	0.000121	0.000585	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000121	0.000583	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GCG—type 2 diabetes mellitus	0.000119	0.000573	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000119	0.000573	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ADCY5—type 2 diabetes mellitus	0.000119	0.000572	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GPX1—type 2 diabetes mellitus	0.000118	0.00057	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CD36—type 2 diabetes mellitus	0.000115	0.000556	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000114	0.000549	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	0.000109	0.000527	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—type 2 diabetes mellitus	0.000109	0.000526	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARA—type 2 diabetes mellitus	0.000107	0.000517	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000106	0.000511	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AGT—type 2 diabetes mellitus	0.000104	0.0005	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GNB3—type 2 diabetes mellitus	0.000102	0.000494	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000102	0.000494	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMOX1—type 2 diabetes mellitus	0.000102	0.000492	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CALM1—type 2 diabetes mellitus	0.000102	0.000492	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOE—type 2 diabetes mellitus	0.000102	0.00049	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAT—type 2 diabetes mellitus	0.000101	0.000485	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA1—type 2 diabetes mellitus	0.0001	0.000485	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOB—type 2 diabetes mellitus	9.77e-05	0.000471	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—type 2 diabetes mellitus	9.76e-05	0.000471	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—type 2 diabetes mellitus	9.5e-05	0.000458	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LPL—type 2 diabetes mellitus	9.33e-05	0.00045	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ADCY5—type 2 diabetes mellitus	9.13e-05	0.000441	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX1—type 2 diabetes mellitus	9.1e-05	0.000439	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CD36—type 2 diabetes mellitus	8.86e-05	0.000428	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—type 2 diabetes mellitus	8.85e-05	0.000427	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPP2CA—type 2 diabetes mellitus	8.75e-05	0.000422	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—INS—type 2 diabetes mellitus	8.68e-05	0.000419	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—type 2 diabetes mellitus	8.4e-05	0.000405	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARA—type 2 diabetes mellitus	8.24e-05	0.000397	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AGT—type 2 diabetes mellitus	7.98e-05	0.000385	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—type 2 diabetes mellitus	7.96e-05	0.000384	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CALM1—type 2 diabetes mellitus	7.85e-05	0.000379	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOE—type 2 diabetes mellitus	7.82e-05	0.000377	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA1—type 2 diabetes mellitus	7.73e-05	0.000373	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.61e-05	0.000367	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NOS3—type 2 diabetes mellitus	7.61e-05	0.000367	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—type 2 diabetes mellitus	6.96e-05	0.000336	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—type 2 diabetes mellitus	6.81e-05	0.000329	CbGpPWpGaD
Fludarabine—DCK—Metabolism—INS—type 2 diabetes mellitus	6.68e-05	0.000322	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—type 2 diabetes mellitus	6.12e-05	0.000295	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3R1—type 2 diabetes mellitus	5.86e-05	0.000283	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NOS3—type 2 diabetes mellitus	5.86e-05	0.000283	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—type 2 diabetes mellitus	5.36e-05	0.000258	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—type 2 diabetes mellitus	3.5e-05	0.000169	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—type 2 diabetes mellitus	2.69e-05	0.00013	CbGpPWpGaD
